Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
Nicola SpotornoiD, Olof E. LindbergiD, Christer NilssoniD, Maria Landqvist WaldöiD, Danielle van WesteniD, Karin Nilsson, Susanna VestbergiD, Elisabet M. EnglundiD, Henrik ZetterbergiD, Kaj BlennowiD, Jimmy LättiD, Markus NilssoniD, Lars‐Olof WahlundiD, Alexander Frizell SantilloiD
Abstract
Neurofilaments are structural components of neurons and are particularly abundant in highly myelinated axons. The levels of neurofilament light chain (NfL) in both cerebrospinal fluid (CSF) and plasma have been related to degeneration in several neurodegenerative conditions including frontotemporal dementia (FTD) and NfL is currently considered as the most promising diagnostic and prognostic fluid biomarker in FTD. Although the location and function of filaments in the healthy nervous system suggests a link between increased NfL and white matter degeneration, such a claim has not been fully elucidated in vivo, especially in the context of FTD. The present study provides evidence of an association between the plasma levels of NfL and white matter involvement in behavioral variant FTD (bvFTD) by relating plasma concentration of NfL to diffusion tensor imaging (DTI) metrics in a group of 20 bvFTD patients. The results of both voxel-wise and tract specific analysis showed that increased plasma NfL concentration is associated with a reduction in fractional anisotropy (FA) in a widespread set of white matter tracts including the superior longitudinal fasciculus, the fronto-occipital fasciculus the anterior thalamic radiation and the dorsal cingulum bundle. Plasma NfL concentration also correlated with cortical thinning in a portion of the right medial prefrontal cortex and of the right lateral orbitofrontal cortex. These results support the hypothesis that blood NfL levels reflect the global level of neurodegeneration in bvFTD and help to advance our understanding of the association between this blood biomarker for FTD and the disease process.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 31
- FWCI
- 4.19
- Field percentile
- top 5%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduced plasma hexosylceramides in frontotemporal dementia are a biomarker of white matter integrity
Oana C. Marian, Sophie Matis, … Anthony Simon Don·Alzheimer s & Dementia Diagnosis Assessment & Disease MonitoringPeer-reviewed·Apr 1, 2025
- Cortical distribution of neurofilaments associates with pathological hallmarks and MRI measures of atrophy and diffusivity in Parkinson's disease
Irene Frigerio, Max A. Laansma, … Laura E. Jonkman·bioRxiv·Aug 10, 2022
- Impact of long- and short-range fiber depletion on the cognitive deficits of fronto-temporal dementia
Melissa Savard, Tharick Ali Pascoal, … On behalf of for the Frontotemporal Lobar Degeneration Neuroimaging Initiative·eLifePeer-reviewed·Jan 24, 2022
- Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype-specific, and severity-linked alterations
Yohannes Abere Ambaw, Peter Alexander Ljubenkov, … Robert V. Farese·Alzheimer s & DementiaPeer-reviewed·Sep 1, 2025
- Cytoarchitectonic gradients of laminar degeneration in behavioral variant frontotemporal dementia
Daniel T. Ohm, Sharon Xiangwen Xie, … David John Irwin·BrainPeer-reviewed·Aug 9, 2024
- Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
André Strydom, Amanda Heslegrave, … Henrik Zetterberg·Alzheimer s Research & TherapyPeer-reviewed·Apr 10, 2018